DarioHealth Corp.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
DRIO$2.06-13.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| Page | |||
|---|---|---|---|
| · · | |||
| Cautionary Note Regarding Forward-Looking Statements | | 3 | |
| | | | |
| PART 1 - FINANCIAL INFORMATION | | | |
| | | | |
| Item 1. | Condensed Consolidated Interim Financial Statements (unaudited) | | F-1 |
| | | | |
| Condensed Consolidated Interim Balance Sheets (Unaudited) | | F-2 – F-3 | |
| | | | |
| Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) | | F-4 | |
| | | | |
| Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited) | | F- 5 – F-6 | |
| | | | |
| Condensed Consolidated Interim Statements of Cash Flows (Unaudited) | | F-7 | |
| | | | |
| Notes to Condensed Consolidated Interim Financial Statements | | F-8 – F-27 | |
| | | | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | | 4 |
| | | | |
| Item 4. | Control and Procedures | | 15 |
| | | | |
| PART II - OTHER INFORMATION | | 16 | |
| | | | |
| Item 1A. | Risk Factors | | 16 |
| | | | |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | | 19 |
| | | | |
| Item 6. | Exhibits | | 20 |
| | | | |
| SIGNATURES | | 22 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.